论文部分内容阅读
目的回顾性分析单硝酸异山梨酯治疗顽固性心力衰竭患者的疗效和安全性。方法随机选择80例顽固性心力衰竭患者,治疗组40例,对照组40例,进行临床资料分析。结果治疗组40例,有效率95%;对照组40例,有效率75%。两组比较有统计学意义。结论在常规治疗顽固性心力衰竭患者的基础上加用单硝酸异山梨酯,可以提高临床疗效,安全,适宜在基层医院推广。
Objective To retrospectively analyze the efficacy and safety of isosorbide mononitrate in patients with refractory heart failure. Methods Eighty patients with refractory heart failure were randomly selected. The treatment group (40 cases) and the control group (40 cases) were performed clinical data analysis. Results The treatment group of 40 cases, 95% efficiency; control group of 40 cases, the effective rate of 75%. The two groups were statistically significant. Conclusion The application of isosorbide mononitrate on the basis of routine treatment of patients with refractory heart failure can improve the clinical efficacy, safety and suitable for promotion in primary hospitals.